AGC Biologics, a provider of clinical and commercial manufacturing services for therapeutic proteins, has appointed Jeffery Mowery as site head/general manager of the Copenhagen, Denmark facility. Mr. Mowery will provide leadership and site management to ensure the continued execution of world-class contract development and manufacturing services. He will support the continuous growth of the Copenhagen facility while working closely with colleagues in Seattle, Heidelberg and Chiba to ensure the business leverages and integrates AGC Biologics combined global capabilities.
 
Mr. Mowery brings 20 years of industry experience in small molecule, biologic and cell/gene therapy production environments. His experience includes working for companies that include Juno Therapeutics, Lonza and Genentech.
 
“We are pleased to have Mr. Mowery, a standout leader within the life sciences industry, join our world class team at AGC Biologics,” said Kasper Moller, chief technology officer, AGC Biologics. “The role of site head/general manager of the Copenhagen facility is essential to our operation’s expansion and growth. Mr. Mowery has the expertise and experience to lead our Copenhagen site in the growth and achievement of our stated goals and objectives.”